Sun Pharmaceutical Industries to Acquire Innovcare Lifesciences for Rs2.71 Billion

Sun Pharmaceutical Industries announced an agreement to acquire the India-based company Innovcare Lifesciences for approximately Rs2.71 billion, or $28.7 million. This transaction marks a strategic expansion for Sun Pharma as it integrates the operations and assets of the Mumbai-based firm into its existing pharmaceutical portfolio.

The acquisition involves a total cash consideration of $28.7 million to secure full ownership of Innovcare Lifesciences. Innovcare currently operates within the nutraceutical and specialized healthcare segments, focusing on products that address various therapeutic needs. By finalizing this purchase, Sun Pharma incorporates these specialized product lines into its broader business operations. The companies confirmed the terms of the agreement on June 22, 2026, setting the stage for the transition of Innovcare’s business interests to the pharmaceutical giant.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 22, 2026

Author

GOAI